Camlin Fine Sciences enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,581	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
109	109	142	80.3	93.7
−40.1	−40.1	−26.9	−7.8	4.7
668	668	646	658	780
2,101	—	—	—	—
560	560	504	577	686
₹109.36	—	—	—	—

1,669	1,669	1,520	1,515	1,604
40.0%	40.0%	42.5%	43.4%	48.6%
0.32×	—	—	—	—

1.13×	—	—	—	—
24.45×	—	—	—	—
202.38×	—	—	—	—
85.74×	—	—	—	—
1,862	1,723	1,667	1,613	1,682
85.9	107	208	73.9	205
10.4	36.0	144	−4.7	143
—	82.1	26.7	139	50.9
24.5	24.5	−15.7	78.4	−93.4
—	23.7	−15.8	78.4	−120
—	57.6	42.4	60.6	144

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CAMLINFINE₹82.32

Camlin Fine Sciences Limited

· Chemicals

₹ CrorePeersCLEAN DEEPAKNTR BAYERCROP TIRUMALCHM ATUL SHK PAUSHAKLTD ANURASMcap ₹1,581 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,581.3
- Cash, Equiv & ST Investments	93.7	80.3	142.1	108.6	108.6
+ Minority Interest	4.7	-7.8	-26.9	-40.1	-40.1
+ Total Debt	779.6	657.7	645.6	668.1	668.1
Enterprise Value	—	—	—	—	2,100.8
Net Debt (memo)	685.8	577.4	503.6	559.5	559.5
EV per Share	—	—	—	—	109.36

Total Capital	1,603.7	1,514.6	1,520.4	1,668.9	1,668.9
Total Debt/Total Capital	48.61	43.42	42.46	40.03	40.03
Total Debt/EV	—	—	—	—	0.32

EV/Sales	—	—	—	—	1.13
EV/EBITDA	—	—	—	—	24.45
EV/EBIT	—	—	—	—	202.38
EV/Free Cash Flow	—	—	—	—	85.74
Reference Items — Trailing FY Values
Sales	1,681.6	1,613.1	1,666.5	1,723.3	1,861.7
EBITDA	205.3	73.9	208.1	106.9	85.9
EBIT	142.8	-4.7	144.3	36.0	10.4
Operating Cash Flow	50.9	139.0	26.7	82.1	—
Free Cash Flow	-93.4	78.4	-15.7	24.5	24.5
FCFF (free cash flow to the firm)	-119.6	78.4	-15.8	23.7	—
Capital Expenditure	144.3	60.6	42.4	57.6	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.